About AVXL

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company engaged in the development of novel drug candidates to treat Alzheimer’s disease, other CNS diseases and various types of cancer.
Primary Exchange: NASDAQ
SIC Services-Commercial Physical & Biological Research
NAICS

AVXL is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
VTI Vanguard Total Stock Market ETF 108.6 B 1.086E+11 3,570 3570 0.0% 0 471 K 470644
VXF Vanguard Extended Market ETF 6.5 B 6.5E+09 3,237 3237 0.0% 3E-05 172 K 171975
ITOT iShares Core S&P Total U.S. Stock Market ETF 21.0 B 2.1005E+10 3,548 3548 0.0% 0 65 K 64506
IWC iShares Microcap ETF 852.8 M 8.52758E+08 1,426 1426 0.04% 0.0004 317 K 316837